HSBC Holdings’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,054
Closed -$104K 2699
2025
Q2
$104K Sell
11,054
-2,543
-19% -$22.4K ﹤0.01% 2840
2025
Q1
$147K Sell
13,597
-38,643
-74% -$389K ﹤0.01% 2707
2024
Q4
$493K Buy
52,240
+38,184
+272% +$386K ﹤0.01% 2184
2024
Q3
$157K Buy
14,056
+3,231
+30% +$34.3K ﹤0.01% 2699
2024
Q2
$107K Buy
10,825
+171
+2% +$1.74K ﹤0.01% 2718
2024
Q1
$123K Buy
+10,654
New +$90.5K ﹤0.01% 2809
2023
Q1
Sell
-20,128
Closed -$386K 2651
2022
Q4
$386K Buy
20,128
+4,955
+33% +$105K ﹤0.01% 2400
2022
Q3
$288K Buy
+15,173
New +$312K ﹤0.01% 2446

Other funds holding AHCO

HSBC Holdings's AHCO Position: Q3 2025 in Review

HSBC Holdings sold out of AdaptHealth (AHCO) in Q3 2025, closing a stake of 11,054 shares — an estimated $104K sold.

HSBC Holdings first reported a position in AHCO in Q3 2022 and held it in 8 quarters. The position peaked at $493K in Q4 2024. 225 funds tracked by Wall St. Rank hold AHCO as of Q3 2025.

  • HSBC Holdings reported no remaining AdaptHealth position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 11,054 AdaptHealth shares in Q3 2025, an estimated $104K.
  • HSBC Holdings first reported a position in AdaptHealth in Q3 2022 and held it in 8 quarters.
  • HSBC Holdings's AdaptHealth position peaked at $493K in Q4 2024.
  • 225 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.